NCT05187897 CHV-NEO: Community-based Digital Communication to Support Neonatal Health
| NCT ID | NCT05187897 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Washington |
| Condition | Neonatal Death |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2024-01-10 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,000 participants in total. It began in 2024-01-10 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Neonatal mortality (defined as death in the first 28 days of life) remains unacceptably high in sub-Sarahan Africa. The concentrated risk of neonatal illness in the first weeks of life and its potential to rapidly deteriorate means that expanding mothers' access to timely information and support during this period is critical to reducing neonatal mortality. This cluster-randomized control trial aims to integrate a 2 way interactive SMS text messaging intervention into existing digital infrastructure supporting Community Health Volunteer (CHV) workflow in Western Kenya (dCHT) to enable remote communication by mothers with CHVs between home visits.
Eligibility Criteria
Inclusion Criteria: * Pregnant * 26-36 weeks gestation * Daily access to a mobile phone (own or shared) * Willing to receive SMS * Age ≥14 years * Able to read and respond to text messages in English, Kiswahili or Luo, or have someone in the household who can help * Receiving antenatal care at study facility * Plan to be in the area for at least 3 months postpartum Exclusion Criteria: * participating in another study * previously participated in this study
Contact & Investigator
Keshet Ronen, MPH, PhD
PRINCIPAL INVESTIGATOR
University of Washington
Frequently Asked Questions
Who can join the NCT05187897 clinical trial?
This trial is open to female participants only, aged 14 Years or older, studying Neonatal Death. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05187897 currently recruiting?
Yes, NCT05187897 is actively recruiting participants. Contact the research team at lpothan@uw.edu for enrollment information.
Where is the NCT05187897 trial being conducted?
This trial is being conducted at Kisumu, Kenya.
Who is sponsoring the NCT05187897 clinical trial?
NCT05187897 is sponsored by University of Washington. The principal investigator is Keshet Ronen, MPH, PhD at University of Washington. The trial plans to enroll 3,000 participants.